pf-08049820
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 27, 2024 (NCT06686797)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07216027 | Phase 2 | Nov 26, 2025 | Pfizer |
| NCT07284173 | Phase 1 | Nov 3, 2025 | Pfizer |
| NCT07190430 | Phase 1 | Oct 3, 2025 | Pfizer |
| NCT07172321 | Phase 1 | Sep 5, 2025 | Pfizer |
| NCT06686797 | Phase 1 | Nov 27, 2024 | Pfizer |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 5 | 5 | 2 | 2024 |
1 organizations
Page 1 / 1